Perhaps sensing trouble on the horizon, it could be a retrospective exercise to provide an ostensible sense of openess and transparency in corporate reporting in case ASIC challenge them about Ophthalmia and other details that warranted BRM disclosure prior to the bid. (still doesn't answer the fundanmental question why BRM is not revalued on Ophthalmia alone - even though the so called independent expert - aka HIRE-A-PEN scam report was all cooked up anyway).
There are no investors to preach to. These bastards have all the shares. The remaining ones are held by us. WNI is a Communist Chinese front. Eventual funding won't come from the odd merchant shipping rich Chinaman but from the Commnunist party coffers in Beijing.
This presentation serves a purpose that's for sure.
BRM Price at posting:
$2.38 Sentiment: Buy Disclosure: Held
